Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Sonoma Pharmaceuticals (SNOA) Cash & Equivalents: 2010-2012

Historic Cash & Equivalents for Sonoma Pharmaceuticals (SNOA) over the last 3 years, with Dec 2012 value amounting to $6.6 million.

  • Sonoma Pharmaceuticals' Cash & Equivalents rose 33.00% to $6.6 million in Q4 2012 from the same period last year, while for Dec 2012 it was $6.6 million, marking a year-over-year increase of 33.00%. This contributed to the annual value of $3.4 million for FY2012, which is 23.34% down from last year.
  • Latest data reveals that Sonoma Pharmaceuticals reported Revenue - Interest and Investment Income of $9.7 million as of Q2 2012, which was up 23.67% from $7.8 million recorded in Q1 2012.
  • Sonoma Pharmaceuticals' 5-year Cash & Equivalents high stood at $8.3 million for Q3 2012, and its period low was $3.4 million during Q1 2012.
  • In the last 2 years, Sonoma Pharmaceuticals' Revenue - Interest and Investment Income had a median value of $9.3 million in 2010 and averaged $9.1 million.
  • Per our database at Business Quant, Sonoma Pharmaceuticals' Cash & Equivalents slumped by 32.51% in 2011 and then spiked by 129.43% in 2012.
  • Sonoma Pharmaceuticals' Revenue - Interest and Investment Income (Quarterly) stood at $8.4 million in 2010, then followed by $9.7 million in 2012.
  • Its Cash & Equivalents was $6.6 million in Q4 2012, compared to $8.3 million in Q3 2012 and $4.4 million in Q2 2012.